Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,002 public trials 2,553 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

NCT06136650

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • The University of Arizona Cancer Center - North Campus ( Site 0073) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0044) Los Angeles, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040) Orange, California, United States
  • Stanford Cancer Center ( Site 0036) Palo Alto, California, United States
View all 330 locations
View Trial Details
Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

NCT07227415

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, +30 more
Locations
  • Mayo Clinic Building- Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 162 locations
View Trial Details
Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

NCT07049926

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • UCSF Medical Center at Mission Bay ( Site 5008) San Francisco, California, United States
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026) Mineola, New York, United States
  • Laura and Isaac Perlmutter Cancer Center ( Site 5016) New York, United States
  • Memorial Sloan Kettering Cancer Center ( Site 5002) New York, United States
View all 32 locations
View Trial Details
Recruiting

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

NCT07109726

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +42 more
Locations
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Mayo Rochester Rochester, Minnesota, United States
  • Washington Univ. School of Medicine St Louis, Missouri, United States
View all 20 locations
View Trial Details
Recruiting

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

NCT05758688

Conditions
Cervical Cancer, Endometrial Cancer, Endometrial Neoplasms, +14 more
Locations
  • Virtua Health Voorhees Township, New Jersey, United States
  • Lancaster General Health - Ann B. Barshinger Cancer Institute Lancaster, Pennsylvania, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions